goetzpartners advised doctari group
goetzpartners advised doctari on its acquisition of Planerio
goetzpartners advised
doctari group on the
of Planerio GmbH
Value not disclosed
Scroll down
Fortlane Partners advised Berlin-based healthcare service provider doctari on the acquisition of Planerio GmbH, the Munich-based provider of AI-supported shift planning and scheduling software for hospitals and medical practices.
Planerio was officially founded in 2016, and today its software is used in over 600 medical practices, clinics and care facilities across Germany, Austria and Switzerland. Planerio shift planning software is continually being developed and thanks to the integration of numerous additional functions & features, such as time recording or payroll accounting, Planerio's software is becoming a leading operating system for human resources management in the healthcare industry.
Fortlane Partners acted as exclusive M&A advisor to doctari, further underlining our competence as advisor of choice in the healthcare industry M&A transactions.
About doctari Group
doctari is Germany’s leading healthcare service provider, combining more than a decade of experience and digital platform solutions with the largest network of medical professionals. The doctari group is a technological pioneer, having launched the very first online booking-platform doctari pro. All companies within the group focus on innovation in workforce management as well as the quality of life of medical professionals thus improving the healthcare system as a whole. doctari is a portfolio company of the international growth equity investor Vitruvian Partners.
Transaction team:
Ulrich Kinzel
Managing Director
More transactionsYou might also be interested in...
Fortlane Partners advised
Exyte on the
of TTP Group
Value not disclosed
goetzpartners advised
Evotec SE on its
of Central Glass Germany GmbH
Value not disclosed
goetzpartners advised
EvoTec SE on the
of Rigenerand Srl
230,000,00 €
goetzpartners advised
Otto Group on the
of Medgate Holding & Better Doc
Value not disclosed
goetzpartners advised
Pharmaron on its
of Aesica Pharmaceuticals from Recipharm
Value not disclosed
goetzpartners advised
Pharmaron on its
of Allergan Biologics from AbbVie
Value not disclosed
goetzpartners advised
EUSA Pharma on the
of the global commercialization rights to the oncology product ISQETTE
Value not disclosed
goetzpartners advised
Penta Investment on the
of Lloyds Pharma
Value not disclosed
goetzpartners advised
Penta Investment on the
of Gehe Pharma
Value not disclosed
goetzpartners advised
KKR and Triton on the
of Ambea
Value not disclosed
goetzpartners advised
Chequers Capital on the
of Silver Care Holding
Value not disclosed
goetzpartners advised
TÜV Süd on the
of MSOURCE from its founder, Dr. Adriaan Hart de Ruijter
Value not disclosed
goetzpartners advised
a financial investor on the
of the Four Seasons Health Care Group
Value not disclosed